Found 212 hits of ic50 data for polymerid = 50000800 Target/Host
(Institution) | Ligand | Target/Host
Links | Ligand
Links | Trg + Lig
Links | Ki
nM | ΔG°
kcal/mole | IC50
nM | Kd
nM | EC50/IC50
nM | koff
s-1 | kon
M-1s-1 | pH | Temp
°C |
|---|
Apolipoprotein L1
(Homo sapiens) | BDBM50547875
(CHEMBL4754532 | US20230271945, Compound 1)Show SMILES O[C@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet 
| Purchase
PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | <250 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
Inhibition of APOL1 (unknown origin) in HEK293 cells assessed as thallium influx incubated for 30 mins by FLIPR based thallium influx assay |
Citation and Details
Article DOI: 10.1021/acsmedchemlett.0c00531
BindingDB Entry DOI: 10.7270/Q25Q50QQ |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM50547876
(CHEMBL4791770 | US20230271945, Compound 20)Show SMILES Fc1cc(F)c2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccc(cc1)C#N |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | <250 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
Inhibition of APOL1 (unknown origin) in HEK293 cells assessed as thallium influx incubated for 30 mins by FLIPR based thallium influx assay |
Citation and Details
Article DOI: 10.1021/acsmedchemlett.0c00531
BindingDB Entry DOI: 10.7270/Q25Q50QQ |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM50547880
(CHEMBL4789274 | US20230271945, Compound 121)Show SMILES COc1ccc(cc1)-c1[nH]c2ccccc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | <250 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
Inhibition of APOL1 (unknown origin) in HEK293 cells assessed as thallium influx incubated for 30 mins by FLIPR based thallium influx assay |
Citation and Details
Article DOI: 10.1021/acsmedchemlett.0c00531
BindingDB Entry DOI: 10.7270/Q25Q50QQ |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM50547878
(CHEMBL4752052 | US20230271945, Compound 61)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cccc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | <250 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
Inhibition of APOL1 (unknown origin) in HEK293 cells assessed as thallium influx incubated for 30 mins by FLIPR based thallium influx assay |
Citation and Details
Article DOI: 10.1021/acsmedchemlett.0c00531
BindingDB Entry DOI: 10.7270/Q25Q50QQ |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM50547879
(CHEMBL4780017 | US20230271945, Compound 82)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2cc(F)c(F)cc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | <250 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
Inhibition of APOL1 (unknown origin) in HEK293 cells assessed as thallium influx incubated for 30 mins by FLIPR based thallium influx assay |
Citation and Details
Article DOI: 10.1021/acsmedchemlett.0c00531
BindingDB Entry DOI: 10.7270/Q25Q50QQ |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM50547877
(CHEMBL4795347 | US20230271945, Compound 42)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(cc(F)cc12)C#N)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| Article
PubMed
| n/a | n/a | <250 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA
| Assay Description
Inhibition of APOL1 (unknown origin) in HEK293 cells assessed as thallium influx incubated for 30 mins by FLIPR based thallium influx assay |
Citation and Details
Article DOI: 10.1021/acsmedchemlett.0c00531
BindingDB Entry DOI: 10.7270/Q25Q50QQ |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM50547875
(CHEMBL4754532 | US20230271945, Compound 1)Show SMILES O[C@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM50547875
(CHEMBL4754532 | US20230271945, Compound 1)Show SMILES O[C@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| Purchase
PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615085
(3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-...)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| MCE
PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615085
(3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-...)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| MCE
PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615086
(3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-...)Show SMILES Fc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615086
(3-[5,7-difluoro-2-(4-fluorophenyl)-1H-indol-3-yl]-...)Show SMILES Fc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615096
(US20230271945, Compound 13)Show SMILES Fc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@@H]1CCNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615097
(US20230271945, Compound 14)Show SMILES CC1(CCNC1=O)NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccc(F)cc1 |w:1.0| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM50547876
(CHEMBL4791770 | US20230271945, Compound 20)Show SMILES Fc1cc(F)c2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccc(cc1)C#N |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM50547876
(CHEMBL4791770 | US20230271945, Compound 20)Show SMILES Fc1cc(F)c2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccc(cc1)C#N |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615102
(US20230271945, Compound 21)Show SMILES FC(F)Oc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615102
(US20230271945, Compound 21)Show SMILES FC(F)Oc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615103
(US20230271945, Compound 22)Show SMILES Cc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@H]1[C@H](O)CNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615104
(US20230271945, Compound 23)Show SMILES Cc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615105
(US20230271945, Compound 24)Show SMILES Cc1ccc(cc1)-c1[nH]c2c(F)cc(F)cc2c1CCC(=O)N[C@@H]1CCNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615106
(US20230271945, Compound 25)Show SMILES Fc1cc(F)c2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615107
(US20230271945, Compound 26)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615107
(US20230271945, Compound 26)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(F)cc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615108
(US20230271945, Compound 27)Show SMILES Fc1ccc(cc1)-c1[nH]c2c(F)cc(Br)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615108
(US20230271945, Compound 27)Show SMILES Fc1ccc(cc1)-c1[nH]c2c(F)cc(Br)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615110
(US20230271945, Compound 29)Show SMILES Cc1cc(F)c2[nH]c(c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c2c1)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615110
(US20230271945, Compound 29)Show SMILES Cc1cc(F)c2[nH]c(c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c2c1)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615111
(US20230271945, Compound 30)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(Cl)cc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615111
(US20230271945, Compound 30)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(F)cc(Cl)cc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615113
(US20230271945, Compound 32)Show SMILES Fc1ccc(cc1)-c1[nH]c2c(F)cc(Cl)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615115
(US20230271945, Compound 34)Show SMILES Fc1ccc(cc1)-c1[nH]c2c(Cl)cc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615116
(US20230271945, Compound 35)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(Cl)cc(F)cc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615117
(US20230271945, Compound 36)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(Cl)cc(F)cc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615117
(US20230271945, Compound 36)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(Cl)cc(F)cc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615118
(US20230271945, Compound 37)Show SMILES Cc1cc(F)cc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615118
(US20230271945, Compound 37)Show SMILES Cc1cc(F)cc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615119
(US20230271945, Compound 38 | US20230271945, Compou...)Show SMILES Cc1cc(F)cc2c(CCC(=O)N[C@H]3CCNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615121
(US20230271945, Compound 40)Show SMILES COc1cc(F)cc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615121
(US20230271945, Compound 40)Show SMILES COc1cc(F)cc2c(CCC(=O)N[C@H]3[C@H](O)CNC3=O)c([nH]c12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM50547877
(CHEMBL4795347 | US20230271945, Compound 42)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(cc(F)cc12)C#N)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM50547877
(CHEMBL4795347 | US20230271945, Compound 42)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2c(cc(F)cc12)C#N)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615124
(3-[2-(4-bromophenyl)-5-methyl-1H-indol-3-yl]-N-[(3...)Show SMILES Cc1ccc2[nH]c(c(CCC(=O)N[C@H]3CCNC3=O)c2c1)-c1ccc(Br)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615125
(3-(5-chloro-2-phenyl-1H-indol-3-yl)-N-[(3S,4R)-4-h...)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(Cl)cc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615125
(3-(5-chloro-2-phenyl-1H-indol-3-yl)-N-[(3S,4R)-4-h...)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(Cl)cc12)-c1ccccc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615126
(3-[5-chloro-2-(4-fluorophenyl)-1H-indol-3-yl]-N-[(...)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(Cl)cc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615127
(US20230271945, Compound 46)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(F)cc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615127
(US20230271945, Compound 46)Show SMILES O[C@@H]1CNC(=O)[C@H]1NC(=O)CCc1c([nH]c2ccc(F)cc12)-c1ccc(F)cc1 |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615128
(US20230271945, Compound 47)Show SMILES Fc1ccc(cc1)-c1[nH]c2ccc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Apolipoprotein L1
(Homo sapiens) | BDBM615128
(US20230271945, Compound 47)Show SMILES Fc1ccc(cc1)-c1[nH]c2ccc(F)cc2c1CCC(=O)N[C@H]1CCNC1=O |r| | PDB
Reactome pathway
KEGG
UniProtKB/SwissProt
DrugBank
GoogleScholar
AffyNet
| PC cid
PC sid
UniChem
| US Patent
| n/a | n/a | 600 | n/a | n/a | n/a | n/a | n/a | n/a |
Celgene Quanticel Research, Inc.
US Patent
| |
US Patent US9725441 (2017)
BindingDB Entry DOI: 10.7270/Q2FJ2MXG |
More data for this
Ligand-Target Pair | |
Search and Browse
